Position in TWST
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$263,926
-$1,719,459 QoQ
Shares Held
5,554
-89.7% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TWST Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Graham Capital Management, L.P. holds $10,662,805 across 8 Diagnostics & Research names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
|
25,748 | $6,989,294 | |
| 2 | DHR |
Danaher Corp /De/
|
10,612 | $2,021,373 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
879 | $462,740 | |
| 4 | MEDP |
Medpace Holdings, Inc.
|
839 | $444,326 | |
| 5 | CRL |
Charles River Laboratories International, Inc.
|
1,454 | $329,752 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
1,121 | $216,599 | |
| 7 | MYGN |
Myriad Genetics Inc
|
28,804 | $164,470 | |
| 8 | OPK |
Opko Health, Inc.
|
22,834 | $34,251 |
All Filings in TWST
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $263,926 | 5,554 | Shares | Sole | 2026-05-15 | |
| 2025-06-30 | $1,983,385 | 53,911 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $923,984 | 23,535 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $809,879 | 17,428 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $630,035 | 13,945 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $690,609 | 14,014 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $763,843 | 22,263 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $575,679 | 15,618 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $304,203 | 15,015 | Shares | Sole | 2023-11-22 | |
| 2020-09-30 | $1,120,405 | 14,748 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,724,163 | 38,061 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||